138 Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds
Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To iden...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ellefson, D.D. [verfasserIn] DiZerega, G.S. [verfasserIn] Mehrian Shai, R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK; Malden, USA: Blackwell Publishing Ltd/Inc. ; 2005 |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2008 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: Wound repair and regeneration - Oxford [u.a.] : Wiley-Blackwell, 1993, 13(2005), 2, Seite 0 |
| Übergeordnetes Werk: |
volume:13 ; year:2005 ; number:2 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1111/j.1067-1927.2005.130216ap.x |
|---|
| Katalog-ID: |
NLEJ243611803 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ243611803 | ||
| 003 | DE-627 | ||
| 005 | 20210707183419.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s2005 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/j.1067-1927.2005.130216ap.x |2 doi | |
| 035 | |a (DE-627)NLEJ243611803 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Ellefson, D.D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 138 Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| 264 | 1 | |a Oxford, UK; Malden, USA |b Blackwell Publishing Ltd/Inc. |c 2005 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 | ||
| 533 | |d 2008 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2008|||||||||| | ||
| 700 | 1 | |a DiZerega, G.S. |e verfasserin |4 aut | |
| 700 | 1 | |a Mehrian Shai, R. |e verfasserin |4 aut | |
| 700 | 1 | |a Rodgers, K.E. |4 oth | |
| 773 | 0 | 8 | |i In |t Wound repair and regeneration |d Oxford [u.a.] : Wiley-Blackwell, 1993 |g 13(2005), 2, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243925980 |w (DE-600)2011990-2 |x 1524-475X |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2005 |g number:2 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2005 |e 2 |h 0 | ||
| author_variant |
d e de g d gd s r m sr srm |
|---|---|
| matchkey_str |
article:1524475X:2005----::3mdltoognepesobnre31i |
| hierarchy_sort_str |
2005 |
| publishDate |
2005 |
| allfields |
10.1111/j.1067-1927.2005.130216ap.x doi (DE-627)NLEJ243611803 DE-627 ger DE-627 rakwb Ellefson, D.D. verfasserin aut 138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc. 2005 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| DiZerega, G.S. verfasserin aut Mehrian Shai, R. verfasserin aut Rodgers, K.E. oth In Wound repair and regeneration Oxford [u.a.] : Wiley-Blackwell, 1993 13(2005), 2, Seite 0 Online-Ressource (DE-627)NLEJ243925980 (DE-600)2011990-2 1524-475X nnns volume:13 year:2005 number:2 pages:0 http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 13 2005 2 0 |
| spelling |
10.1111/j.1067-1927.2005.130216ap.x doi (DE-627)NLEJ243611803 DE-627 ger DE-627 rakwb Ellefson, D.D. verfasserin aut 138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc. 2005 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| DiZerega, G.S. verfasserin aut Mehrian Shai, R. verfasserin aut Rodgers, K.E. oth In Wound repair and regeneration Oxford [u.a.] : Wiley-Blackwell, 1993 13(2005), 2, Seite 0 Online-Ressource (DE-627)NLEJ243925980 (DE-600)2011990-2 1524-475X nnns volume:13 year:2005 number:2 pages:0 http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 13 2005 2 0 |
| allfields_unstemmed |
10.1111/j.1067-1927.2005.130216ap.x doi (DE-627)NLEJ243611803 DE-627 ger DE-627 rakwb Ellefson, D.D. verfasserin aut 138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc. 2005 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| DiZerega, G.S. verfasserin aut Mehrian Shai, R. verfasserin aut Rodgers, K.E. oth In Wound repair and regeneration Oxford [u.a.] : Wiley-Blackwell, 1993 13(2005), 2, Seite 0 Online-Ressource (DE-627)NLEJ243925980 (DE-600)2011990-2 1524-475X nnns volume:13 year:2005 number:2 pages:0 http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 13 2005 2 0 |
| allfieldsGer |
10.1111/j.1067-1927.2005.130216ap.x doi (DE-627)NLEJ243611803 DE-627 ger DE-627 rakwb Ellefson, D.D. verfasserin aut 138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc. 2005 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| DiZerega, G.S. verfasserin aut Mehrian Shai, R. verfasserin aut Rodgers, K.E. oth In Wound repair and regeneration Oxford [u.a.] : Wiley-Blackwell, 1993 13(2005), 2, Seite 0 Online-Ressource (DE-627)NLEJ243925980 (DE-600)2011990-2 1524-475X nnns volume:13 year:2005 number:2 pages:0 http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 13 2005 2 0 |
| allfieldsSound |
10.1111/j.1067-1927.2005.130216ap.x doi (DE-627)NLEJ243611803 DE-627 ger DE-627 rakwb Ellefson, D.D. verfasserin aut 138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc. 2005 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| DiZerega, G.S. verfasserin aut Mehrian Shai, R. verfasserin aut Rodgers, K.E. oth In Wound repair and regeneration Oxford [u.a.] : Wiley-Blackwell, 1993 13(2005), 2, Seite 0 Online-Ressource (DE-627)NLEJ243925980 (DE-600)2011990-2 1524-475X nnns volume:13 year:2005 number:2 pages:0 http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 13 2005 2 0 |
| source |
In Wound repair and regeneration 13(2005), 2, Seite 0 volume:13 year:2005 number:2 pages:0 |
| sourceStr |
In Wound repair and regeneration 13(2005), 2, Seite 0 volume:13 year:2005 number:2 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Wound repair and regeneration |
| authorswithroles_txt_mv |
Ellefson, D.D. @@aut@@ DiZerega, G.S. @@aut@@ Mehrian Shai, R. @@aut@@ Rodgers, K.E. @@oth@@ |
| publishDateDaySort_date |
2005-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243925980 |
| id |
NLEJ243611803 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243611803</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707183419.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2005 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1067-1927.2005.130216ap.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243611803</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ellefson, D.D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK; Malden, USA</subfield><subfield code="b">Blackwell Publishing Ltd/Inc.</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2008</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2008||||||||||</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">DiZerega, G.S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrian Shai, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodgers, K.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Wound repair and regeneration</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1993</subfield><subfield code="g">13(2005), 2, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925980</subfield><subfield code="w">(DE-600)2011990-2</subfield><subfield code="x">1524-475X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2005</subfield><subfield code="e">2</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Ellefson, D.D. |
| spellingShingle |
Ellefson, D.D. 138 Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| authorStr |
Ellefson, D.D. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243925980 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK; Malden, USA |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1524-475X |
| topic_title |
138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| publisher |
Blackwell Publishing Ltd/Inc. |
| publisherStr |
Blackwell Publishing Ltd/Inc. |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k r kr |
| hierarchy_parent_title |
Wound repair and regeneration |
| hierarchy_parent_id |
NLEJ243925980 |
| hierarchy_top_title |
Wound repair and regeneration |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243925980 (DE-600)2011990-2 |
| title |
138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| ctrlnum |
(DE-627)NLEJ243611803 |
| title_full |
138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| author_sort |
Ellefson, D.D. |
| journal |
Wound repair and regeneration |
| journalStr |
Wound repair and regeneration |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2005 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Ellefson, D.D. DiZerega, G.S. Mehrian Shai, R. |
| container_volume |
13 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ellefson, D.D. |
| doi_str_mv |
10.1111/j.1067-1927.2005.130216ap.x |
| author2-role |
verfasserin |
| title_sort |
138
modulation of gene expression by norleu3a(1–7) in diabetic wounds |
| title_auth |
138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| abstract |
Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 |
| abstractGer |
Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 |
| abstract_unstemmed |
Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481 |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
2 |
| title_short |
138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds |
| url |
http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x |
| remote_bool |
true |
| author2 |
DiZerega, G.S. Mehrian Shai, R. Rodgers, K.E. |
| author2Str |
DiZerega, G.S. Mehrian Shai, R. Rodgers, K.E. |
| ppnlink |
NLEJ243925980 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1111/j.1067-1927.2005.130216ap.x |
| up_date |
2024-07-06T06:00:29.020Z |
| _version_ |
1803808280696324096 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243611803</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707183419.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2005 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1067-1927.2005.130216ap.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243611803</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ellefson, D.D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">138
Modulation of Gene Expression by Norleu3A(1–7) in Diabetic Wounds</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK; Malden, USA</subfield><subfield code="b">Blackwell Publishing Ltd/Inc.</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Neuropathic ulcers represent a significant cause of morbitity for diabetics in the United States. Diabetic wounds are notoriously difficult to resolve. Treatment options are limited due in part to the lack of knowledge about the molecular events that regulate successful resolution of wounds. To identify differences between normal and diabetic gene regulation in wounds, we examined the level of expression of 12,000 genes in granulation tissue and wound-edge epithelium in normal animals and in an experimental model of diabetes following induction of full thickness skin injuries. Full thickness injuries in diabetic mice were characterized in part by altered regulation of structural genes and genes that regulate energy metabolism and utilization. The energy cycle contributes backbone structures for the synthesis of a variety of amino acids, the molecular building blocks essential for wound repair. A direct consequence of a diminished ability to efficiently exploit energy supplies would be decreased availability of regulatory and structural proteins necessary for efficient healing in diabetic wounds. We have successfully enhanced healing in diabetic wounds by treatment with the angiotensin II peptide NorLeu3A(1–7). NorLeu3A(1–7) accelerates healing of full thickness injuries in diabetic mice. While NorLeu3A(1–7) enhances healing by accelerating collagen deposition and reepithelialization, gene array studies show that NorLeu3A(1–7) acts locally within the wound site by altering gene expression within the granulation tissue. Specifically at day 7 after injury, NorLeu3A(1–7) reduced the expression of MMP genes and increase the expression of genes involved in energy metabolism.Supported by PHS grant NIAMS 2 R44 AR47481</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2008</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2008||||||||||</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">DiZerega, G.S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrian Shai, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodgers, K.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Wound repair and regeneration</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1993</subfield><subfield code="g">13(2005), 2, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925980</subfield><subfield code="w">(DE-600)2011990-2</subfield><subfield code="x">1524-475X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1067-1927.2005.130216ap.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2005</subfield><subfield code="e">2</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.401453 |